Diabetes Discourse
As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease.
Because when it comes to diabetes, glucose control is just the beginning.
31-45 of 214
Investigating the Impact of Bempedoic Acid on Cardiovascular Outcomes in Statin-Intolerant Patients
Diabetes DiscourseInvestigating the Impact of Bempedoic Acid on Cardiovascular Outcomes in Statin-Intolerant Patients
John Buse, MD, PhD
Steven Nissen, MD
Addressing Gaps to Tackle Obesity in Patients with Type 1 Diabetes
Diabetes DiscourseAddressing Gaps to Tackle Obesity in Patients with Type 1 Diabetes
John Buse, MD, PhD
Elizabeth Selvin, PhD, MPH
Closing Gaps in Care for Patients with T2D & CV Disease
Diabetes DiscourseClosing Gaps in Care for Patients with T2D & CV Disease
John Buse, MD, PhD
Jennifer B. Green, MD
Maximizing Weight Loss & Minimizing Side Effects With GLP-1
Diabetes DiscourseMaximizing Weight Loss & Minimizing Side Effects With GLP-1
John Buse, MD, PhD
Ania Jastreboff, MD, PhD
Adapting Our Exercise Talk: Key Tips on Counseling Patients on Exercise
Diabetes DiscourseAdapting Our Exercise Talk: Key Tips on Counseling Patients on Exercise
John Buse, MD, PhD
Abbie E. Smith-Ryan, PhD, CSCS*D, FNSCA
Insights from Obesity Canada: A Deep Dive into Guideline Updates
Diabetes DiscourseInsights from Obesity Canada: A Deep Dive into Guideline Updates
John Buse, MD, PhD
Sue Pedersen, MD, FRCPC
- advertisement
Key Therapeutic Insights on Semaglutide in Adolescent Obesity
Diabetes DiscourseKey Therapeutic Insights on Semaglutide in Adolescent Obesity
John Buse, MD, PhD
Silva Arslanian, MD
Explore Impacts Of Glucose-Lowering Medications in Addition to Metformin
Diabetes DiscourseExplore Impacts Of Glucose-Lowering Medications in Addition to Metformin
John Buse, MD, PhD
Jennifer B. Green, MD
Key Insights from GRADE: Exploring Data on Glycemia Reduction in T2D
Diabetes DiscourseKey Insights from GRADE: Exploring Data on Glycemia Reduction in T2D
John Buse, MD, PhD
Deborah Wexler, MD
Breaking Down the Bionic Pancreas: A Device for Dosing Decisions for T1D
Diabetes DiscourseBreaking Down the Bionic Pancreas: A Device for Dosing Decisions for T1D
John Buse, MD, PhD
Steven Russell, MD, PhD
An Assessment of Automated Insulin Delivery Systems for T1D
Diabetes DiscourseAn Assessment of Automated Insulin Delivery Systems for T1D
John Buse, MD, PhD
Martin de Bock, PhD FRACP
A Look at Comprehensive Telehealth for PPDM
Diabetes DiscourseA Look at Comprehensive Telehealth for PPDM
John Buse, MD, PhD
Matthew Crowley, MD
- advertisement
SNAP, Food Insecurity, & Healthcare Spending: What Do We Need to Know?
Diabetes DiscourseSNAP, Food Insecurity, & Healthcare Spending: What Do We Need to Know?
John Buse, MD, PhD
Seth Berkowitz, MD, MPH
Getting to Know GRADE: A Comparative Study of T2D Treatment
Diabetes DiscourseGetting to Know GRADE: A Comparative Study of T2D Treatment
John Buse, MD, PhD
Ashok Balasubramanyam, MD
Exploring Precision Medicine in the Treatment of Diabetes
Diabetes DiscourseExploring Precision Medicine in the Treatment of Diabetes
John Buse, MD, PhD
Jose C. Florez, MD, PhD
